News

Capstan Medical Secures $110M to Bring First-of-its-Kind Robotics Technology to Heart Disease Patients

Led by Eclipse, the round will further allow the company to bring the benefits of robotics to one of the few remaining untouched areas of medicine and structural heart

Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases

MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 million Series B financing round.

Be bolder: What leaders can learn from CU Boulder’s successes in research, innovation, and football

Recognize that it’s never too late to rebuild and revive your organization. If a public university of almost 150 years of history could do it, why can’t yours?

Transforming Medicine: Aqtual Secures $16M Series A to Pioneer Precision Treatment Solutions Copy

Aqtual secures $16M Series A to revolutionize precision medicine, offering hope for personalized treatments in diseases like rheumatoid arthritis and cancer.

Breaking Barriers: Elve's $15M Series A Funding Propels Wireless Revolution

Elve's $15M Series A funding marks a milestone in revolutionizing wireless internet access worldwide. Proud to support their groundbreaking work! 🚀

InsightFinder $10M Series A Empowers IT With Incident Prevention

InsightFinder predicts and prevents outages in complex distributed IT architectures through the company’s unique patented technology for unsupervised stream learning and pattern-driven auto-remediation.

From Boulder to the Bay: Alumni investors connect with university startups at Silicon Valley summit

On August 17, eight University of Colorado startups founded on faculty research traveled to Silicon Valley for a day-long retreat with CU Boulder alumni investors and friends.The investors are members of the Bay Area Buffs Investors Club, a grassroots alumni organization founded by Pingrong “PR” Yu (PhDChem’04), a Silicon Valley-based venture capitalist, startup founder and CU Boulder alumnus.

$25.3M Raised for Leo Cancer Care to Continue Their Mission to be ‘The More Human Way to Deliver Radiation Therapy’

Leo Cancer Care is dedicated to being the more human way to deliver radiation therapy. Their family of world class radiation therapy solutions can provide a streamlined and efficient treatment, whilst making the patient feel in control and hopeful. Leo Cancer Care has been built on research from across the globe showing the clinical benefits of upright patient positioning. Combining this with a shift from machine rotation to patient rotation, Leo Cancer Care is set to make radiation therapy more accessible than ever before.